Joseph A. Vetro, Ph.D

Assistant Professor

Department of Pharmaceutical Sciences
College of Pharmacy
University of Nebraska Medical Center
College of Pharmacy Room 3033
986025 Nebraska Medical Center
Omaha, NE 68198-6025
402-559-9359 (Office)
402-559-1975 (Lab)
402-559-9543 (Fax)
jvetro@unmc.edu

Teaching Activities:

Pharmacy Doctorate Students

Pharmaceutical Sciences 570: Bioavailability & Bioequivalence, rate processes of drug release, drug absorption, parenterals, biotechnology-derived products, nasal, pulmonary and opthalmic delivery.

Pharmaceutical Sciences Graduate Students

Quantitative Pharmaceutical Sciences 845: DNA, RNA and proteins

Pharm Chem for Drug Delivery 826: Surface modification of micro and nanospheres, synthesis of biodegradable nanogels

Innovative Drug Delivery Systems 851: Biological barriers to drug delivery

Physical Pharmacy 885: Mass transfer

Research Activities/Interests:

Dr. Vetro's research interests are in developing novel synthetic targeted drug and gene delivery nanocarriers for the anti-angiogenesis treatment of cancer, improving development paradigms for targeted bioimaging and drug delivery nanocarriers and developing subunit vaccines based on the novel adjuvant, EP67.

Please visit the Nanomedicine Group Website for further information.

Recent Publications:

  1. Lobo B.S.; Vetro J.A.; Suich D.M.; Zuckermann R.N.; Middaugh C.R.; Structure/functional analysis of peptoid/lipitoid:DNA complexes J. Pharm. Sci.  92(9): pp.1905-1918. 2003
  2. Vetro J.A.; Dummitt B.; Chang Y.H.;  Methionine aminopeptidase: Emerging role in angiogenesis. in Aminopeptidases in Biology and Disease. Eds. Hooper NM and Lendeckel U, Kluwer: New York, New York, pp. 17-44. 2004
  3. Braun C.S.; Vetro J.A.; Koe G.S.; Koe J.G.; Tomalia D.A.; Middaugh C.R.;  Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles.  J. Pharm. Sci. 94(2): pp. 423-436. 2005
  4. Batrakova E.V.; Bronich T.K.; Vetro J.A.; Kabanov A.V.;  Polymeric Micelles as Drug Carriers in Nanoparticulates as Drug Carriers, Ed. Torchilin, V, Imperial College Press: London, UK. pp. 57-93. 2006
  5. Vetro, J.A.; Delivery, Detection and Development in Nanomedicine. Nanomedicine. 1(4): pp. 487-489. 2006
  6. Kakiuci-Kiyota, S.; Vetro, J.A.; Suzuki, S.; Varney, M.L.; Han, H-Y.; Nascimento, M.; Pennington, K.L.; Arnold, L.L.; Singh, R.K.; Cohen, S.M.; Evaluation of Effects of Troglitazone on Endothelial Cells in Vivo and in Vitro: Differences Between Mouse and Human. Toxicol Appl Pharmacol. 237: pp. 83-90. 2009 
  7. Ambardekar, V.V.; Han, H-Y.; Varney, M.L.; Vinogradov, S.V.; Singh, R.K.; Vetro, J.A.; The Modification of siRNA with 3' Cholesterol to Increase Nuclease Protection and Suppression of Native mRNA by Select siRNA Polyplexes. Biomaterials, 32: pp. 1404-1411. 2011
  8. Haney, M.J.; Zhao, Y.; Li, S.; Higginbotham, S.M.; Booth, S.L.; Han, H-Y.; Vetro, J.A.; Mosley, R.L.; Kabanov, A.V.; Gendelman, H.E.; Batrakova, E.V.; Cell-mediated transfer of Catalase Nanoparticles from Macrophages to Brain Endothelial, Glial and Neuronal Cells. Nanomedicine (in press) 2011

Joseph Vetro, Ph.D.
Joe Vetro